Amneal reports second quarter 2022 financial results

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (“amneal” or the “company”) announced its results today for the second quarter ended june 30, 2022. “solid second quarter results reflect topline growth across all three segments and meaningful acceleration in performance from the first quarter. our core business is strong as we expect acceleration in the second half of 2022 and further momentum in the years ahead. on the horizon are a number of key catalyst launches
AMRX Ratings Summary
AMRX Quant Ranking